Synthesis, cytotoxic activity and docking studies of new 4-aza-podophyllotoxin derivatives

Belani PC, Doyle AL, Aisner J (1994) Etoposide: current status and future perspectives in the management of malignant neoplasmas. Cancer Chemother Pharmacol 34:S118–S126

Dengler WA, Schulte J, Berger DP, Mertelsmann R, Fiebig HH (1995) Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anticancer Drugs 6:522–532

George MN, Constantin D, Octavian TO (2013) New potent antitumor pyrazole derivatives: synthesis and cytotoxic evaluation. Int J Mol Sci 14:21805–21818

Gordaliza M, Castro AM, Corral MMJ, Feliciano AS (2000) Antitumor properties of podophyllotoxin and related compounds. Curr Pharm Des 6:1811–1839

Hande RK (1998) Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 34:1514–1521

Hitotsuyanagi Y, Kobayashi M, Fukuyo M, Takeya K, Itokawa H (1997) A facile synthesis of the 4-aza-analogs of 1-arylnaphthalene lignans chinensin, justicidin B and taiwanin C. Tetrahedron Lett 38:8295–8296

Hitotsuyanagi Y, Fukuyo M, Tsuda K, Kobayashi M, Ozeki A, Itokawa H, Takeya K (2000) 4-aza-2,3-dehydro-4-deoxypodophyllotoxins: simple aza-podophyllotoxin analogues possessing potent cytotoxicity. Bioorg Med Chem Lett 10:315–317

Kamal A, Suresh P, Mallareddy A, Kumar BA, Reddy PV, Raju P, Tamboli JR, Shaik TB, Jain N, Kalivendi SV (2011) Synthesis of a new 4-aza-2,3-didehydro Podophyllotoxin analogues as potent cytotoxic and antimitotic agents. Bioorg Med Chem 19:2349–2358

Kamal A, Tamboli JR, Nayak VL, Adil SF, Vishnuvardhan MVPS, Ramakrishna S (2014) Synthesis of a terphenyl substituted 4-aza-2,3-didehydropodophyllotoxin analogues as inhibitors of tubulin polymerization and apoptosis inducers. Bioorg Med Chem 22:2714–2723

Kobayashi K, Ratain MJ (1994) Pharmacodynamics and long-term toxicity of etoposide. Cancer Chemother Pharmacol 34:S64–S68

Lee KH, Kinghorn AD, Balandrin M (1993) American Chemical Society (eds) ACS Symposium Series No 534, Washington, DC, p 170

Loike DJ, Brewer FC, Sternlicht H, Gensler JW, Horwitz BS (1978) Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Cancer Res 38:2688–2693

Macdonald TL, Lehnert EK, Loper JT, Chow KC, Ross WE, Potmesil M, Kohn KW (eds) (1991) DNA topoisomerase in cancer. Oxford University, New York, p 199

MacRae WD, HudsonJB Towers GHN (1993) The antiviral action of lignans. Planta Med 55:531–535

Magedov IV, Manpadi M, Slambrouck SV, Steelant WFA, Rozhkova E, Przheval’skii NM, Rogelj S, Kornienko A (2007) Discovery and investigation of antiproliferative and apoptosis-inducing properties of new heterocyclic podophyllotoxin analogues accessible by a one-step multicomponent synthesis. J Med Chem 50:5183–5192

Nguyen CH, Lhoste JM, Lavelle F, Bissery MC, Bisagni E (1990) Synthesis and antitumor activity of 1-[[(dialkylamino)alkyl]amino]-4-methyl-5H-pyrido[4,3-b]benzo[e]- and -benzo[g] indoles. A new class of antineoplastic agents. J Med Chem 33:1519–1528

Schacter L (1996) Etoposide phosphate: what, why, where, and how? Semin Oncol 23:1–7

Shi F, Zhang S, Wu S-S, Gao Y, Tu S-J (2011a) A diversity-oriented synthesis of pyrazolo[4,3-f]quinoline derivatives with potential bioactivities via microwave-assisted multi-component reactions. Mol Divers 15:497–505

Shi F, Zeng X-N, Zhang G, Ma N, Jiang B, Tu S (2011b) Facile synthesis of new 4-aza-podophyllotoxin analogs via microwave-assisted multi-component reactions and evaluation of their cytotoxic activity. Bioorg Med Chem Lett 21:7119–7123

Showalter HD, Angelo MM, Shillis JL (1998) Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemias. J Med Chem 31:1527–1539

Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren TW, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer drug screening. J Nat Cancer Inst 82:1107–1112

Stähblin H (1970) 4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action. Eur J Cancer 6:303–306

Stähblin H (1973) Activity of a new glycosidic lignan derivative (VP-16-213) related to podophyllotoxin in experimental tumors. Eur J Cancer 9:215–221

Witterland HA, Koks HC, Beijinen H (1996) J Pharm World Sci 18:63

Youngjae Y (2005) Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents. Curr Pharm Des 11:1695–1717